Stem Cell Research

As a medical office that prides itself on the highest quality of patient care, Neurosurgery Associates is also committed to keeping up-to-date on the latest breakthroughs in neurosurgery and offering cutting-edge treatment options for its patients. Dr. Shehadi and his team have a profound interest in regenerative and translational medicine, specifically involving stem cells.
Dr. Shehadi is currently offering regenerative medicine options to patients now with a whole host of neurological and neurosurgical issues. Although there is evidence that these interventions work for some patients, the treatments are still not FDA approved yet, and thus insurance does not pay. (must be cash pay). Dr. Shehadi works with the Phenicell Regenerative Institute to treat and to study the regenerative benefits from stem cells and platelet rich plasma (PRP). Please read below or visit phenicell.com for greater detail.
Stem cells are a naturally occurring group of cells found in adult human body. Stem cells have the ability to grow and differentiate into many different types of cells, and can therefore be used to regenerate tissue and encourage healing. Dr. Shehadi’s creative and forward-thinking approach to patient care includes harnessing the versatile power of stem cells to promote bone growth and spinal cord repair or regeneration if possible. We are using and studying stem cells and PRP for the following conditions:

• Lumbar pain from intervertebral disk degeneration
• Facilitating bony spine fusions
• Spinal cord repair after spinal cord injury
• Traumatic brain injury
• Multiple sclerosis
• Knee pain
• Shoulder pain

Medical Device Development

Dr. Joseph A. Shehadi, MD partners up with industry, and constantly strives to improve the safety of medically implantable spinal devices and advance the field. Neurosurgery Associates uses several different implants from companies such as Alliance Spine  and Synthes.

Research Article

In 2020, Dr. Shehadi published a research article titled: “Combined administration of platelet-rich plasma and autologous bone marrow aspirate concentrate for spinal cord injury: a descriptive case series.”

The authors are Joseph A. Shehadi, Steven M. Elzein, Paul Beery, M. Chance Spalding, Michelle Pershing.

Research Article

In 2017, Dr. Shehadi published a research article titled: “Review of commercially available demineralized bone matrix products for spinal fusions: A selection paradigm”

The authors are Joseph A. Shehadi and Steven M. Elzein.

Teaching of Neurosurgical Resident for Ohio University:

Dr. Shehadi has been teaching neurosurgical residents for over ten years. He holds the title of Clinical Professor of Neurosurgery at Ohio University, which is based in Athens, OH.

Teaching of Physician Assistant for Ohio Dominican University:

Dr. Shehadi has been teaching physician Assistants for the past few years. This consists of a one month rotation in neurosurgery. He holds the position of Clinical Instructor at Ohio Dominican University (ODU).